NICE approves brain cancer drug following change to cost-effectiveness thresholds
Vorasidenib, a daily pill, has been approved for people aged over 12 years who have astrocytoma or oligodendroglioma with isocitrate...
RPS Charter Award given for pharmacist’s ‘global impact’
The Royal Pharmaceutical Society said Catherine Duggan has been ldquo;a strong advocate for improving access to safe, effective and high-quality...
Implementing a pharmacy-led post‑discharge medicines counselling service for patients prescribed high‑risk medicines
...
Some pathfinder sites capped or closed as national funding ends
National funding to support community pharmacy prescribing sites under the ‘Independent prescribing in community pharmacy pathfinder programme came to an...
Director of pharmacy appointed for Royal College of Pharmacy
Justine Scanlan will lead on the royal college's ambitions to champion pharmacy with policymakers, partners and stakeholders across Great Britain....
Easter: a season of renewed hope and positive momentum
...